JP2014144011A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014144011A5 JP2014144011A5 JP2014075577A JP2014075577A JP2014144011A5 JP 2014144011 A5 JP2014144011 A5 JP 2014144011A5 JP 2014075577 A JP2014075577 A JP 2014075577A JP 2014075577 A JP2014075577 A JP 2014075577A JP 2014144011 A5 JP2014144011 A5 JP 2014144011A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- interferor
- molecule
- self
- specific
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 108090000623 proteins and genes Proteins 0.000 description 9
- 102000004169 proteins and genes Human genes 0.000 description 9
- 230000002776 aggregation Effects 0.000 description 3
- 230000008827 biological function Effects 0.000 description 3
- 238000004220 aggregation Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 108050001049 Extracellular proteins Proteins 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 230000003828 downregulation Effects 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 230000004845 protein aggregation Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US75324505P | 2005-12-22 | 2005-12-22 | |
| EP05112761.1 | 2005-12-22 | ||
| EP05112761 | 2005-12-22 | ||
| US60/753,245 | 2005-12-22 | ||
| EP06125189.8 | 2006-12-01 | ||
| EP06125189 | 2006-12-01 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008546487A Division JP5888832B2 (ja) | 2005-12-22 | 2006-12-22 | タンパク質干渉を媒介する手段および方法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016221100A Division JP2017074046A (ja) | 2005-12-22 | 2016-11-14 | タンパク質干渉を媒介する手段および方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014144011A JP2014144011A (ja) | 2014-08-14 |
| JP2014144011A5 true JP2014144011A5 (enExample) | 2016-05-19 |
Family
ID=40785299
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008546487A Expired - Fee Related JP5888832B2 (ja) | 2005-12-22 | 2006-12-22 | タンパク質干渉を媒介する手段および方法 |
| JP2014075577A Withdrawn JP2014144011A (ja) | 2005-12-22 | 2014-04-01 | タンパク質干渉を媒介する手段および方法 |
| JP2016221100A Withdrawn JP2017074046A (ja) | 2005-12-22 | 2016-11-14 | タンパク質干渉を媒介する手段および方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008546487A Expired - Fee Related JP5888832B2 (ja) | 2005-12-22 | 2006-12-22 | タンパク質干渉を媒介する手段および方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016221100A Withdrawn JP2017074046A (ja) | 2005-12-22 | 2016-11-14 | タンパク質干渉を媒介する手段および方法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (3) | JP5888832B2 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5888832B2 (ja) * | 2005-12-22 | 2016-03-22 | フラームス・インテルウニフェルシタイル・インステイチュート・フォール・ビオテヒノロヒー・ヴェーゼットウェー（ヴェーイーベー・ヴェーゼットウェー）Ｖｌａａｍｓ Ｉｎｔｅｒｕｎｉｖｅｒｓｉｔａｉｒ Ｉｎｓｔｉｔｕｕｔ Ｖｏｏｒ Ｂｉｏｔｅｃｈｎｏｌｏｇｉｅ Ｖｚｗ（Ｖｉｂ Ｖｚｗ） | タンパク質干渉を媒介する手段および方法 |
| CN103547296B (zh) * | 2011-03-11 | 2016-08-17 | 非营利性组织佛兰芒综合大学生物技术研究所 | 用于抑制和检测蛋白质的分子和方法 |
| US20230287046A1 (en) * | 2020-02-19 | 2023-09-14 | Aelin Therapeutics | Molecules targeting proteins |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5854204A (en) * | 1995-03-14 | 1998-12-29 | Praecis Pharmaceuticals, Inc. | Aβ peptides that modulate β-amyloid aggregation |
| US20030064384A1 (en) * | 2001-04-02 | 2003-04-03 | Mien-Chie Hung | Beta-catenin is a strong and independent prognostic factor for cancer |
| EP1325930A1 (en) * | 2002-01-08 | 2003-07-09 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Mammal prolactin variants |
| JP5888832B2 (ja) * | 2005-12-22 | 2016-03-22 | フラームス・インテルウニフェルシタイル・インステイチュート・フォール・ビオテヒノロヒー・ヴェーゼットウェー（ヴェーイーベー・ヴェーゼットウェー）Ｖｌａａｍｓ Ｉｎｔｅｒｕｎｉｖｅｒｓｉｔａｉｒ Ｉｎｓｔｉｔｕｕｔ Ｖｏｏｒ Ｂｉｏｔｅｃｈｎｏｌｏｇｉｅ Ｖｚｗ（Ｖｉｂ Ｖｚｗ） | タンパク質干渉を媒介する手段および方法 |
-
2006
- 2006-12-22 JP JP2008546487A patent/JP5888832B2/ja not_active Expired - Fee Related
-
2014
- 2014-04-01 JP JP2014075577A patent/JP2014144011A/ja not_active Withdrawn
-
2016
- 2016-11-14 JP JP2016221100A patent/JP2017074046A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2018001387A (es) | Anticuerpo de dominio simple y proteinas derivadas del mismo contra ligando de muerte programada (pdl1). | |
| WO2017024317A3 (en) | Methods to induce targeted protein degradation through bifunctional molecules | |
| WO2017015622A3 (en) | Gdf11 binding proteins and uses thereof | |
| EP3777830C0 (en) | OPHTHALMIC COMPOSITION FOR THE TREATMENT OF DRY EYE DISEASE | |
| SG10201909716RA (en) | Modified j-chain | |
| WO2014186599A3 (en) | Anti-complement factor c1s antibodies and uses thereof | |
| WO2016100985A3 (en) | Chimeric antigen receptors and methods of use thereof | |
| EA201990778A1 (ru) | Анти-il-33 антитела и их применение | |
| WO2015132675A3 (en) | Methods and compositions for modifying the immune response | |
| EA201791710A1 (ru) | Антитела к транстиретину | |
| EA201791711A1 (ru) | Антитела к транстиретину | |
| WO2015117088A3 (en) | Antibody based reagents that specifically recognize neurodegenerative disease related forms of the protein tdp-43 | |
| WO2016040824A3 (en) | METHODS OF IDENTIFYING MODULATORS OF SESTRIN-GATOR2 INTERACTION AND USE OF SAME TO MODULATE mTORC1 | |
| ZA201804079B (en) | Lactoferrin for use in the diagnosis or prognosis of alzheimer's disease, or in the diagnosis of parkinson's disease | |
| SG10201805646WA (en) | Angiopoietin-like 4 antibodies and methods of use | |
| WO2015191892A3 (en) | α1-ANTITRYPSIN COMPOSITIONS AND METHODS OF TREATING AUTOIMMUNE DISEASES | |
| WO2015143512A3 (en) | Enhancement of recombinant protein expression with copper | |
| Citanna et al. | Refinements and incentive efficiency in Walrasian models of insurance economies | |
| Strickman | Buzz Kill | |
| Vakulenko | Specifics of Covering Demographic Issues in Print Media | |
| 門村亜珠沙 | Ubiquitous computing for improving daily behaviors | |
| Dzhangiryan | Vatican and Wider Europe (Review of book by Bykova GI «Vatican Foreign Policy in the European region in the 1990-2012») | |
| Trajković | Šetnja gradom | |
| Analyses on Alfred Nobel's Will | ||
| Mouslikova | Revised 27-02-14 8: 37am |